Lymphocyte Biology Laboratory, The Francis Crick Institute, London, United Kingdom.
Ragon Institute of MGH, MIT and Harvard, Cambridge, United States.
Elife. 2018 Jan 16;7:e26556. doi: 10.7554/eLife.26556.
Wiskott-Aldrich syndrome (WAS) is an immune pathology associated with mutations in WAS protein (WASp) or in WASp interacting protein (WIP). Together with the small GTPase Cdc42 and other effectors, these proteins participate in the remodelling of the actin network downstream of BCR engagement. Here we show that mice lacking the adaptor protein ITSN2, a G-nucleotide exchange factor (GEF) for Cdc42 that also interacts with WASp and WIP, exhibited increased mortality during primary infection, incomplete protection after Flu vaccination, reduced germinal centre formation and impaired antibody responses to vaccination. These defects were found, at least in part, to be intrinsic to the B cell compartment. In vivo, ITSN2 deficient B cells show a reduction in the expression of SLAM, CD84 or ICOSL that correlates with a diminished ability to form long term conjugates with T cells, to proliferate in vivo, and to differentiate into germinal centre cells. In conclusion, our study not only revealed a key role for ITSN2 as an important regulator of adaptive immune-response during vaccination and viral infection but it is also likely to contribute to a better understanding of human immune pathologies.
威特综合征(Wiskott-Aldrich syndrome,WAS)是一种免疫病理学疾病,与 WAS 蛋白(WASp)或与 WASp 相互作用蛋白(WIP)的突变有关。这些蛋白与小 GTP 酶 Cdc42 及其它效应物一起,参与 B 细胞受体(BCR)结合后肌动蛋白网络的重塑。在这里,我们发现缺乏衔接蛋白 ITSN2 的小鼠在原发性感染期间死亡率增加,流感疫苗接种后保护不完全,生发中心形成减少,对疫苗的抗体反应受损。这些缺陷至少部分是 B 细胞本身的内在缺陷。在体内,ITSN2 缺陷型 B 细胞中 SLAM、CD84 或 ICOSL 的表达减少,这与与 T 细胞形成长期共轭的能力下降、体内增殖和分化为生发中心细胞的能力下降有关。总之,我们的研究不仅揭示了 ITSN2 作为疫苗接种和病毒感染期间适应性免疫反应的重要调节剂的关键作用,而且可能有助于更好地理解人类免疫病理学。